Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;41(8):999-1006.
doi: 10.1093/jjco/hyr092. Epub 2011 Jul 15.

Burden on oncologists when communicating the discontinuation of anticancer treatment

Hiroyuki Otani  1 , Tatsuya Morita, Taito Esaki, Hiroshi Ariyama, Koichiro Tsukasa, Akira Oshima, Keiko Shiraisi
Affiliations

Burden on oncologists when communicating the discontinuation of anticancer treatment

Hiroyuki Otani et al. Jpn J Clin Oncol. 2011 Aug.

Abstract

Objective: Communicating the discontinuation of anticancer treatment to patients is a difficult task. The primary aim of this study was to clarify the level of oncologist-reported burden when communicating about discontinuation of an anticancer treatment. The secondary aims were (i) to identify the sources of burden contributing to their levels and (ii) to explore the useful strategies to alleviate their burden.

Methods: A multicenter nationwide questionnaire survey was conducted on 620 oncologists across Japan (response rate, 67%).

Results: High levels of perceived burden were reported by 47% of respondents, and 17% reported that they sometimes, often or always wanted to stop oncology work because of this burden. There was a significant association between high levels of burden and: a feeling that breaking bad news would deprive the patient of hope; concern that the patient's family would blame the oncologist; concern that the patient may lose self-control; and a feeling that there was not enough time to break the bad news. Strategies perceived to be useful by oncologists included training in how to effectively communicate to patients discontinuation of anticancer treatment, a reduction in total workload to allow sufficient time to break bad news, and development of a multidisciplinary model to facilitate cooperation with other professionals and facilities.

Conclusions: Many oncologists reported high levels of burden relating to communication of discontinuation of anticancer treatment. A specific communication skills training program, sufficient time for communication and development of a multidisciplinary model could help alleviate the burden on oncologists.

PubMed Disclaimer

References

    1. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin. 2005;55:164–77. - PubMed
    1. Peretti-Watel P, Bendiane MK, Obadia Y, Lapiana JM, Galinier A, Pegliasco H, et al. Disclosure of prognosis to terminally ill patients: attitudes and practices among French physicians. J Palliat Med. 2005;8:280–90. - PubMed
    1. Peretti-Watel P, Bendiane MK, Pegliasco H, Lapiana JM, Favre R, Galinier A, et al. Doctors' opinions on euthanasia, end of life care, and doctor-patient communication: telephone survey in France. BMJ. 2003;327:595–6. - PMC - PubMed
    1. Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L. Oncologists' attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189–96. - PubMed
    1. Ptacek JT, Ptacek JJ, Ellison NM. ‘I'm sorry to tell you … ’ physicians' reports of breaking bad news. J Behav Med. 2001;24:205–17. - PubMed

Publication types